These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2190233

  • 1. Stereostructure activity relationships of catecholamines on human platelet function.
    Ahn CH, Shams G, Schotzinger RL, Miller DD, Feller DR.
    Proc Soc Exp Biol Med; 1990 Jun; 194(2):149-56. PubMed ID: 2190233
    [Abstract] [Full Text] [Related]

  • 2. Alpha-adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: in vitro.
    Ahn CH, Hamada A, Miller DD, Feller DR.
    Biochem Pharmacol; 1986 Nov 15; 35(22):4095-102. PubMed ID: 3022751
    [Abstract] [Full Text] [Related]

  • 3. Epinephrine induced platelet aggregation in rat platelet-rich plasma.
    Yun-Choi HS, Park KM, Pyo MK.
    Thromb Res; 2000 Dec 15; 100(6):511-8. PubMed ID: 11152931
    [Abstract] [Full Text] [Related]

  • 4. Apparent heterogeneous responsiveness of human platelet rich plasma to catecholamines.
    Pyo MK, Yun-Choi HS, Hong YJ.
    Platelets; 2003 May 15; 14(3):171-8. PubMed ID: 12850841
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and alpha 2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogues in human platelets.
    Miller DD, Hamada A, Clark MT, Adejare A, Patil PN, Shams G, Romstedt KJ, Kim SU, Intrasuksri U, McKenzie JL.
    J Med Chem; 1990 Apr 15; 33(4):1138-44. PubMed ID: 2157007
    [Abstract] [Full Text] [Related]

  • 6. O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet alpha 2-adrenoceptors.
    Lenz T, Werle E, Strobel G, Weicker H.
    Can J Physiol Pharmacol; 1991 Jul 15; 69(7):929-37. PubMed ID: 1683267
    [Abstract] [Full Text] [Related]

  • 7. Regulation of canine platelet function II. Catecholamines.
    Meyers KM, Huston LY, Clemmons RM.
    Am J Physiol; 1983 Jul 15; 245(1):R100-9. PubMed ID: 6869571
    [Abstract] [Full Text] [Related]

  • 8. Structure activity relationships between catecholamines and the alpha-adrenergic receptor responsible for the aggregation of human platelets by epinephrine.
    Rossi EC, Louis G, Zeller EA.
    J Lab Clin Med; 1979 Feb 15; 93(2):286-94. PubMed ID: 219117
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V, Armstrong PC, Warner TD, Curzen N.
    Platelets; 2015 Feb 15; 26(7):689-92. PubMed ID: 25734957
    [Abstract] [Full Text] [Related]

  • 10. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM, Forscher CA, Sussman II, Mueller HS.
    Am Heart J; 1985 Jun 15; 109(6):1258-63. PubMed ID: 2988323
    [Abstract] [Full Text] [Related]

  • 11. Interaction of berberine with human platelet alpha 2 adrenoceptors.
    Hui KK, Yu JL, Chan WF, Tse E.
    Life Sci; 1991 Jun 15; 49(4):315-24. PubMed ID: 1649363
    [Abstract] [Full Text] [Related]

  • 12. Restricted alpha- and beta-adrenoceptor affinity of sulfoconjugated catecholamines in human mononuclear leukocytes, platelets, and fat cells and reduction of the postreceptor mechanisms.
    Werle E, Michel G, Lenz T, Kather H, Schneider B, Weicker H.
    Int J Sports Med; 1988 Aug 15; 9 Suppl 2():S93-102. PubMed ID: 2846457
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of imidazoline agents on the aggregation of human platelets.
    Pinthong D, Songsermsakul P, Rattanachamnong P, Kendall DA.
    J Pharm Pharmacol; 2004 Feb 15; 56(2):213-20. PubMed ID: 15005880
    [Abstract] [Full Text] [Related]

  • 15. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ, Shattil SJ, Ferry N, Rozansky D, Insel PA.
    Mol Pharmacol; 1986 Jan 15; 29(1):1-6. PubMed ID: 2418346
    [Abstract] [Full Text] [Related]

  • 16. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA, Reimann S, Schrör K.
    Br J Pharmacol; 1999 Jan 15; 126(2):415-20. PubMed ID: 10077233
    [Abstract] [Full Text] [Related]

  • 17. Effect on human platelets of catecholamines at levels achieved in the circulation.
    Ardlie NG, McGuiness JA, Garrett JJ.
    Atherosclerosis; 1985 Dec 15; 58(1-3):251-9. PubMed ID: 3004519
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW, Cooper B, Handin RI.
    J Clin Invest; 1978 May 15; 61(5):1136-44. PubMed ID: 207726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.